MYRIAD GROUP AG

Insiders Myriad Group AG

Equities

MYRN

CH0019624805

Delayed Swiss Exchange Other stock markets			5-day change	1st Jan Change
- ^CHF	-.--%		-27.92%	-62.93%

Jul. 03	Syncona Invests Additional $42.5 Million in Beacon Therapeutics	MT
Jun. 20	Syncona Invests in Two Oncology Companies	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Myriad Group AG Announces Board Appointments	17-08-24	CI
Myriad Group AG announces Extraordinary General Meeting to be held on 24 August 2017, to approve capital increase and nomination of new Director	17-07-27	TE
Myriad Group Announces Resignation of Mauro Saladini from Board of Directors	17-04-27	CI
Myriad Group AG Announces Executive Changes	17-01-30	CI
Myriad Group AG Announces Cessation of Olivier Bartholot as Chief Revenue Officer, Effective December 31, 2015	15-12-30	CI
Myriad Group AG Announces Board Changes	14-05-15	CI
Myriad Group AG Names Olivier Bartholot as Chief Revenue Officer	14-04-24	CI
Mike Grant and Andrew Wyse to step down as Chief Marketing Officer and VP Global Sales from Myriad Group AG, Effective December 31, 2013	13-12-23	CI
Myriad Group AG Announces Changes to its Executive Management Team	13-08-05	CI
Myriad Group AG Announces Board Changes	13-04-19	CI
Myriad Group AG Appoints Stephen Dunford as Chief Executive Officer	12-12-04	CI
Myriad Group AG Announces Changes to Executive Team	12-09-26	CI
Myriad Group AG Proposes David Arnott and Richard K. Schlauri as Non-Executive Members of the Board of Directors	12-05-17	CI
Myriad Group AG Announces Change in the Board of Directors of Company	12-05-03	CI
Myriad Group AG Announces Executive Changes	12-04-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer